Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Healthcare Company (ACHC) Gains from Investment Securities (2016 - 2026)

Acadia Healthcare Company (ACHC) has disclosed Gains from Investment Securities for 17 consecutive years, with $542000.0 as the latest value for Q1 2026.

  • For Q1 2026, Gains from Investment Securities fell 54.94% year-over-year to $542000.0; the TTM value through Mar 2026 reached -$6.1 million, down 610.74%, while the annual FY2025 figure was $185610.0, 73.29% down from the prior year.
  • Gains from Investment Securities hit $542000.0 in Q1 2026 for Acadia Healthcare Company, up from -$10.8 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $3.7 million in Q4 2024 and bottomed at -$10.8 million in Q4 2025.
  • Average Gains from Investment Securities over 5 years is $249307.9, with a median of $478000.0 recorded in 2022.
  • On a YoY basis, Gains from Investment Securities climbed as much as 18910.37% in 2025 and fell as far as 394.8% in 2025.
  • Acadia Healthcare Company's Gains from Investment Securities stood at $170000.0 in 2022, then skyrocketed by 155.29% to $434000.0 in 2023, then surged by 742.17% to $3.7 million in 2024, then tumbled by 394.8% to -$10.8 million in 2025, then surged by 105.03% to $542000.0 in 2026.
  • According to Business Quant data, Gains from Investment Securities over the past three periods came in at $542000.0, -$10.8 million, and $168920.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.